Yu X P, Hustmyer F G, Garvey W T, Manolagas S C
Section of Endocrinology and Metabolism, Veterans Administration Medical Center, Indianapolis, IN.
Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8347-51. doi: 10.1073/pnas.88.19.8347.
Using Western blot analysis with a monoclonal antibody recognizing a 17-amino acid epitope of the 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]receptor, we have detected two crossreacting proteins in activated normal human lymphocytes. The smaller of the two proteins (50 kDa) was indistinguishable from the classical 1,25(OH)2D3 receptor and, similar to the classical 1,25(OH)2D3 receptor, was upregulated in a dose-dependent fashion by 1,25(OH)2D3. The larger crossreacting protein exhibited an electrophoretic mobility of 80 kDa, was localized in the cell cytosol, and appeared to be specific for activated lymphocytes since it was not detected in several other human cells including monocytes. More strikingly, the 80-kDa protein was downregulated in a dose-dependent fashion by 1,25(OH)2D3; this effect was independent of the mode of lymphocyte activation and specific for the 1,25(OH)2D3 metabolite of vitamin D3. However, two potent immunosuppressive agents, glucocorticoids and cyclosporin A, also inhibited the 80-kDa protein.
使用一种识别1,25 - 二羟基维生素D3 [1,25(OH)2D3]受体17个氨基酸表位的单克隆抗体进行蛋白质印迹分析,我们在活化的正常人淋巴细胞中检测到两种交叉反应蛋白。两种蛋白中较小的一种(50 kDa)与经典的1,25(OH)2D3受体无法区分,并且与经典的1,25(OH)2D3受体类似,会被1,25(OH)2D3以剂量依赖性方式上调。较大的交叉反应蛋白表现出80 kDa的电泳迁移率,定位于细胞质中,似乎是活化淋巴细胞所特有的,因为在包括单核细胞在内的其他几种人类细胞中未检测到。更引人注目的是,80 kDa蛋白会被1,25(OH)2D3以剂量依赖性方式下调;这种效应与淋巴细胞活化方式无关,且对维生素D3的1,25(OH)2D3代谢物具有特异性。然而,两种强效免疫抑制剂,即糖皮质激素和环孢素A,也会抑制80 kDa蛋白。